Rallybio (RLYB) Revenue & Revenue Breakdown
Rallybio Revenue Highlights
0
Latest Revenue (Q)
$299.00K
Rallybio Revenue by Period
Rallybio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Rallybio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $299.00K | - |
2024-06-30 | $299.00K | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $228.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Rallybio Revenue Breakdown
Rallybio Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Sep 24 |
---|---|
Collaboration And License Revenue | $299.00K |
Latest
Rallybio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MOLN | Molecular Partners | $7.04M | $2.74M |
IPSC | Century Therapeutics | $2.23M | $791.00K |
MNOV | MediciNova | $1.00M | - |
OPT | Opthea | $108.41K | $61.27K |
CGEM | Cullinan Oncology | - | - |
CCCC | C4 Therapeutics | - | - |
ANTX | AN2 Therapeutics | - | - |
PHVS | Pharvaris | - | - |
RLYB | Rallybio | - | $299.00K |
ELYM | Eliem Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
THRD | Third Harmonic Bio | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |
PEPG | PepGen | - | - |